| Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination NH Schultz, IH Sørvoll, AE Michelsen, LA Munthe, F Lund-Johansen, ... New England journal of medicine 384 (22), 2124-2130, 2021 | 1488 | 2021 |
| How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? OAW Haabeth, AA Tveita, M Fauskanger, F Schjesvold, KB Lorvik, ... Frontiers in immunology 5, 174, 2014 | 240 | 2014 |
| Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study I Jyssum, H Kared, TT Tran, AT Tveter, SA Provan, J Sexton, ... The Lancet Rheumatology 4 (3), e177-e187, 2022 | 139 | 2022 |
| Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model H Almåsbak, E Walseng, A Kristian, MR Myhre, EM Suso, LA Munthe, ... Gene therapy 22 (5), 391-403, 2015 | 138 | 2015 |
| Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells A Os, S Bürgler, AP Ribes, A Funderud, D Wang, KM Thompson, ... Cell reports 4 (3), 566-577, 2013 | 131 | 2013 |
| The PI3K p110δ isoform inhibitor idelalisib preferentially inhibits human regulatory T cell function S Chellappa, K Kushekhar, LA Munthe, GE Tjønnfjord, EM Aandahl, ... The Journal of Immunology 202 (5), 1397-1405, 2019 | 127 | 2019 |
| B-cells and their targeting in rheumatoid arthritis—current concepts and future perspectives B Nakken, LA Munthe, YT Konttinen, AK Sandberg, Z Szekanecz, P Alex, ... Autoimmunity reviews 11 (1), 28-34, 2011 | 110 | 2011 |
| Naive CD4+ T cells confer idiotype‐specific tumor resistance in the absence of antibodies B Bogen, L Munthe, A Sollien, P Hofgaard, H Omholt, F Dagnaes, ... European journal of immunology 25 (11), 3079-3086, 1995 | 102 | 1995 |
| Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells E Lunde, LA Munthe, A Vabø, I Sandlie, B Bogen Nature biotechnology 17 (7), 670-675, 1999 | 75 | 1999 |
| Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor E Blichfeldt, LA Munthe, JS Røtnes, B Bogen European journal of immunology 26 (12), 2876-2884, 1996 | 67 | 1996 |
| Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells LA Munthe, A Corthay, A Os, M Zangani, B Bogen The Journal of Immunology 175 (4), 2391-2400, 2005 | 62 | 2005 |
| Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell–derived IFN-γ by a T-bet–dependent mechanism S Bürgler, A Gimeno, A Parente-Ribes, D Wang, A Os, S Devereux, ... The Journal of Immunology 194 (2), 827-835, 2015 | 60 | 2015 |
| Resting small B cells present endogenous immunoglobulin variable‐region determinants to idiotope‐specific CD4+ T cells in vivo LA Munthe, JA Kyte, B Bogen European journal of immunology 29 (12), 4043-4052, 1999 | 58 | 1999 |
| Lymphomas can develop from B cells chronically helped by idiotype-specific T cells MM Zangani, M Frøyland, GY Qiu, LA Meza-Zepeda, JL Kutok, ... The Journal of experimental medicine 204 (5), 1181-1191, 2007 | 57 | 2007 |
| Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia S Holm, H Kared, AE Michelsen, XY Kong, TB Dahl, NH Schultz, ... European Heart Journal 42 (39), 4064-4072, 2021 | 55 | 2021 |
| Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults H Kared, AS Wolf, A Alirezaylavasani, A Ravussin, G Solum, TT Tran, ... Nature communications 13 (1), 4165, 2022 | 54 | 2022 |
| MHC-restricted Ig V region-driven TB lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production LA Munthe, A Os, M Zangani, B Bogen The Journal of Immunology 172 (12), 7476-7484, 2004 | 48 | 2004 |
| Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies KU Lundin, PO Hofgaard, H Omholt, LA Munthe, A Corthay, B Bogen Blood 102 (2), 605-612, 2003 | 48 | 2003 |
| Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations M König, ÅR Lorentzen, HM Torgauten, S Schikora-Rustad, EB Vaage, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (1), 19-22, 2023 | 46 | 2023 |
| Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy SW Syversen, I Jyssum, AT Tveter, TT Tran, J Sexton, SA Provan, ... Arthritis & Rheumatology 74 (8), 1321-1332, 2022 | 43 | 2022 |
Fridtjof Lund-JohansenDepartment of Immunology, Oslo University Hospital, Oslo, NorwayGeverifieerd e-mailadres voor rr-research.no
